Commensal microorganisms in the human gut produce numerous metabolites by using
small molecules derived from the host or diet as precursors. Host or dietary lipid molecules …

Functional gastrointestinal disorders (FGIDs), chronic disorders characterized by either
abdominal pain, altered intestinal motility, or their combination, have a worldwide …

Much research describes gut microbiota in atherosclerotic cardiovascular diseases
(ASCVD) for that the composition of the intestinal microbiome or its metabolites can directly …

In a study published in Cell, Hu and colleagues discovered that the signaling activity of the
intestinal hormone Cholesin leads to the attenuation of hepatic cholesterol synthesis in …

Background Consumption of whole grains is associated with a reduction in chronic diseases
and offers benefits for cardiovascular health and metabolic regulation. The relationship …

Although the liver is the largest metabolic organ in the body, it is not alone in functionality
and is assisted by “an organ inside an organ,” the gut microbiota. This review attempts to …

Background The gut microbiota can be influenced by lipid metabolism. We aimed to
evaluate the impact of lipid-lowering medications, such as proproteinconvertase …

Parkinson's disease (PD) is the second most common neurodegenerative disorder and
lacks disease-modifying therapies. We developed a Drosophila model for identifying novel …

The Framingham Heart Study is an ongoing observational cohort study to identify risk factors
for cardiovascular disease. Xavier and colleagues used data from study participants to …

Gut bacteria can break down cholesterol | Nature Reviews Cardiology Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …